| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000014382 |
| Receipt No. | R000016714 |
| Official scientific title of the study | A Study of Safety and Efficacy of DPP-4 inhibitor in the Treatment of type 2 diabetes in Kanagawa |
| Date of disclosure of the study information | 2014/06/27 |
| Last modified on | 2018/12/28 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | A Study of Safety and Efficacy of DPP-4 inhibitor in the Treatment of type 2 diabetes in Kanagawa | |
| Title of the study (Brief title) | ASSET-K | |
| Region |
|
|
| Condition | ||
| Condition | Type 2 diabetes | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We research the long-term efficacy and safety of sitagliptin after 4-5 years treatment in Japanese type 2 diabetes patients.
(Retrospective Study) |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Changes of HbA1c |
| Key secondary outcomes | 1)Change of fasting plasma glucose level, body weight, Serum lipids [TC, HDL-C, TG, LDL-C], serum creatinine, office blood pressure,AST,ALT,gamma-GTP,BUN,uric acid,urine protein,
2)adverse events |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Type 2 diabetic outpatients
2) Patients treated with Sitagliptin for more than 4-5 years whose blood sugar control is inadequate 3) Patients aged >=20 years |
|||
| Key exclusion criteria | 1) Patients with a history of hypersensitivity to Sitagliptin
2) Patients who have history of diabetic ketoacidosis, or diabetic coma in the past 6 months 3) Patients with serious infectious disease, before operation, serious trauma 4) Patients with severe renal failure |
|||
| Target sample size | 860 | |||
| Research contact person | |
| Name of lead principal investigator | Akira Kubota |
| Organization | Kubota clinic of Internal Medicine |
| Division name | Director |
| Address | 2708-1 Noborito,tama-ku,Kawasaki,Kanagawa |
| TEL | 044-932-0161 |
| kubota@sj8.so-net.ne.jp | |
| Public contact | |
| Name of contact person | Kou Kayukawa |
| Organization | Nouvelle Place Inc |
| Division name | R.M.O |
| Address | Yushima 1-chome Building,1-6-3 Yushima, bunkyo-ku,Tokyo |
| TEL | 03-3814-1616 |
| Homepage URL | |
| asset-k@n-place.co.jp | |
| Sponsor | |
| Institute | Diabetes Committee, Kanagawa Physicians Association |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The Waksman Foundation of Japan |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | ASSET-K investigators |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | ASSET-K研究グループ(神奈川県):松葉医院,かなもり内科,神内科,いしかわ内科クリニック,たくま幸クリニック,高井内科クリニック,笹井医院,雨宮内科医院,的場内科クリニック,本厚木メディカルクリニック,センター北伊藤内科,川田医院,港南台家光クリニック,H.E.Cサイエンスクリニック,くぬぎ台診療所,みながわ内科クリニック,おばな内科クリニック,もくぼ内科クリニック,向ヶ丘久保田内科,宮入内科,衣笠病院,横須賀市立市民病院,早稲田医院,ほしの内科クリニック,まちむら内科クリニック,武田クリニック,もとみや内科クリニック,かねしろ内科クリニック,鶴間かねしろ内科クリニック |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | https://www.jstage.jst.go.jp/article/tonyobyo/61/11/61_773/_article/-char/ja |
| Results | |
| Other related information | Observational study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016714 |